Board of Directors
Our board of directors consists of business professionals, scientists, and public officials who have the vision to see protons as the future of radiation therapy in cancer treatment.
John Cameron, PhD
Founder, Chairman, President & Director
Dr. Cameron has a long and distinguished career in nuclear physics, medical technology, applications of accelerators, and research and development administration, and is among the pioneers in proton therapy. He played a pivotal role in the development of the Midwest Proton Radiotherapy Institute in Bloomington, Indiana, leading it from initial funding through construction. Dr. Cameron served as professor of physics and director of the Indiana University Cyclotron Facility and has directed major multidisciplinary research and development institutes from 1984 to 2004. He has received more than $200 million in grants and contracts and served on numerous advisory and review boards for U.S. and foreign research agencies. Dr. Cameron was elected Fellow of the American Physical Society in 1987.
Dr. Cameron received his undergraduate degree in 1962 from Queens University, Northern Ireland, with first class honors, and his PhD from the University of California, Los Angeles (UCLA) in 1967.
David S. Chernow
David S. Chernow is President & Chief Development and Strategy Officer of Select Medical, a leading provider of specialized health care in both inpatient and outpatient settings. He previously served as a director of Select Medical from January 2002 until February 2005, and again from August 2005 until September 2010. From May 2007 to February 2010, Mr. Chernow served as the President and Chief Executive Officer of Oncure Medical Corp., a national network of cancer treatment centers. From 2001 to 2007, he was President and Chief Executive Officer of JA Worldwide (formerly known as Junior Achievement). From 1999 to 2001, he was the President of the Physician Services Group at US Oncology, Inc. Mr. Chernow co-founded American Oncology Resources in 1992 and served as its Chief Development Officer until the time of the merger with Physician Reliance Network, Inc., which created US Oncology, Inc. in 1999.
Steven H. Kapp
Steven Kapp is a limited partner of Maverick Capital, a New York-based private investment partnership. He is responsible for the healthcare investment portfolio at Maverick. Prior to Maverick, he was a general partner of Longwood Partners. Prior to Longwood, Mr. Kapp was an officer in corporate development at Airgas, Inc. He earned a BA in Economics and an MBA from the University of North Carolina at Chapel Hill. Mr. Kapp currently serves on the Board of Children’s Scholarship Fund Philadelphia. He resides in Chestnut Hill with his wife and three children.
Ron K. Labrum
Ron K. Labrum is chief executive officer of Fenwal Blood Technologies. Prior to Fenwal, Mr. Labrum served as chairman and chief executive officer of Cardinal Health in its $70 billion Supply Chain Services group. He has also held various top-tier posts with Allegiance Healthcare Corporation. Mr. Labrum began his career with American Hospital Supply Corporation in 1982, which became part of Baxter Healthcare in 1985. His last post at Baxter was President of the southwest region.
Aubrey K. McClendon
Aubrey K. McClendon is chief executive officer and a director of Chesapeake Energy, the largest independent producer of natural gas in the United States. Mr. McClendon co-founded the company in 1989. From 1982 to 1989, he was an independent oil and gas producer. Mr. McClendon graduated from Duke University in 1981.